• Skip to main content
  • Skip to secondary menu
  • Skip to footer
Clinical Digital Resource Collaborative

Clinical Digital Resource Collaborative

Designed and developed in the North East and North Cumbria by local GPs

National Health Service
  • Home
  • About Us
  • The Team
  • Resources
    • Referral Forms
    • EMIS Resources
      • CDRC EMIS Access
      • Long Term Condition (LTC) Management
      • Impact and Investment Fund (IIF)
      • Medicine Management
        • Precision Monitoring
        • DMARDs and High Risk Drugs
        • Safe Prescribing of Opioids / Opiates
      • Specialties
        • Cancer Guide for EMIS
        • EMIS Cardiovascular Overview
          • Atrial Fibrillation Guide for EMIS
          • CDRC Precision CVD Prevention Template
          • Lipids, Familial Hypercholesterolaemia (FH), PCSK9i & Inclisiran Guide for EMIS
          • Peripheral Arterial Disease EMIS Guide
        • Infection
          • Infections Guide for EMIS
          • Blood Borne Virus (BBV)
        • Neurology Guide for EMIS
        • Respiratory Overview
          • BeatAsthma+
    • SystmOne Resources
      • National Early Warning Score 2 (NEWS2) Guide for SystmOne
      • Getting Started
        • Getting Started – Access
        • Getting Started – How-To’s
      • SystmOne Administration
      • Contract Management
        • Impact and Investment Fund (IIF)
        • Vaccinations
      • Long Term Condition Management
        • Call/ Recall System
        • Recall Recovery System
        • Care Planning
      • Safeguarding System
        • Safeguarding Adults
        • Safeguarding At Risk of Harming Others
        • Safeguarding Family/Household Cause for Concern
        • Safeguarding Children
      • Medicine Management
        • Drugs Requiring Monitoring System
        • Safety & Reviews
        • Safe Prescribing of Opioids / Opiates
        • Safe Prescribing of NSAIDS
        • Safe Prescribing of Lithium
        • Safe Prescribing of Valproate
        • Safe Prescribing of Corticosteroids / Steroids
      • Specialties
        • Blood Borne Virus (BBV) Test Alert for SystmOne
        • BeatAsthma+ Guide for SystmOne
        • Cancer Overview
          • Cancer
          • Suspected Cancer
        • Cardiovascular Overview
          • Cardiology Results
          • Hypertension & Blood Pressure
          • Atrial Fibrillation (AF)
          • Integrated CVD Prevention
          • Peripheral Arterial Disease (PAD)
        • SystmOne Diabetes Overview
          • SystmOne Diabetes Management
          • SystmOne Diabetes Prevention
          • SystmOne Diabetic Kidney Disease
        • ENT Infections
        • Geriatrics Overview
          • Care for Frail Patients
          • Comprehensive Geriatric Assessment
          • Co-ordinated Care
        • Haematology
        • Infection Overview
        • Learning Disabilities
        • Lifestyle
        • Lipids, Familial Hypercholesterolaemia, PCSK9i & Inclisiran Overview
          • Lipids, Familial Hypercholesterolaemia (FH), PCSK9i & Inclisiran Search Guide for SystmOne
          • Lipids Protocols
          • Lipids Opt-In Resources
          • Lipid Details and Lipid Lowering Templates
          • Lipid Lowering Template
          • Lipid QoF Support
          • Screening for Familial Hypercholesterolaemia
          • Aetiology of Abnormal Lipids
          • Lipids Strategy
          • Lipids – Recommended Batch Searches
        • MSK Referral Management
        • Neurology
        • Obesity Resources
        • Ophthalmology
        • Palliative Care
        • SystmOne Renal/Urology Overview
          • Chronic Kidney Disease (CKD)
        • Respiratory Overview
          • Asthma Resources
          • Respiratory Infections
        • Rheumatology Overview
          • Bone Health
      • Women’s Health Overview
        • Gynaecology Resource Overview
          • Cervical Screening
          • Contraception
          • Prolapse
      • Vaccination Overview
        • COVID-19 Resources- SystmOne
        • Influenza Vaccination
        • Meningitis B Vaccination
        • Meningitis ACWY Vaccination
        • Pneumococcal Vaccination
        • Shingles Vaccination
  • FAQs
  • News and Events
    • Demonstrations
    • Events
      • Recordings
    • Articles
    • Conference abstracts
  • Contact us
You are here: Home / Resources / SystmOne Resource Centre / SystmOne Specialties / Cardiovascular Overview / Hypertension & Blood Pressure

Hypertension & Blood Pressure

There are several resources available to support you with the detection, intervention and management of Hypertension and Blood Pressure. 

Accessing CDRC resources on SystmOne

To access the below resources you will need to be a member of the DCS group on SystmOne. To do this, please follow the instructions on the CDRC SystmOne Access webpage.

Reports

The following reports are available to identify patients with possible or un-coded Hypertension and will help target patients for intervention. Performance Reports allow you to assess the blood pressure performance of your unit. 

Detecting Possible Hypertension

The following reports identify people not currently on the Hypertension register, whose last blood pressure was high. Different thresholds are set to enable prioritisation of assessment.

These reports are in the folder CDRC Quality > Cardiovascular

  • ? Hypertension/BP 1.1 Screening Priority 1 – Consider repeat BP Last BP >=170/105 #
  • ? Hypertension/BP 1.2 Screening Priority 2 – Consider repeat BP Last BP >=160/100 #
  • ? Hypertension/BP 1.3 Screening Priority 3 – Consider repeat BP Last BP >=150/90 #
  • ? Hypertension/BP 1.4 Screening Priority 4 – Consider repeat BP Last BP >=140/90 #
  • ? Hypertension/BP 1.5 Screening – Other Groups 1.1 BAME – Consider repeat BP Last BP >=140/90
  • ? Hypertension/BP 1.5 Screening – Other Groups 1.2 Core20Plus5 – Consider repeat BP Last BP >=140/90
  • ? Hypertension/BP 1.5 Screening – Other Groups 1.3 Hard to reach – Consider repeat BP Last BP >=140/90
  • ? Hypertension/BP 1.5 Screening – Other Groups 1.4 Hardest to reach – Consider repeat BP Last BP >=140/90

If your unit has opted into the optional Hypertension Resources or Cardiovascular Resources (see ‘Hypertension Opt-in Resources’ below), these patients will be flagged with the raised BP icon.

Potential Hypertension 
Last was >140/90 - consider repeat

Consider inviting these patients for a follow up blood pressure or home blood pressure testing. Patients can be invited systematically using the searches or opportunistically using the patient status alert flag. 

It might also be possible to direct them to local pharmacies taking part in the hypertension finding scheme. 

Detecting Un-Coded Hypertension

The following reports will help identify patients that may not have been appropriately coded. 

These reports are in the folder CDRC Quality > Cardiovascular:

Report NameReturnsAction
? Hypertension/BP 2.1 Casefinding – Potential Hypertension indicator but no HT code Patients with a code to suggest hypertension (e.g. hypertension annual review) without a QoF hypertension code The QoF and Contracting template will help to identify the codes (see example below) 
? Hypertension/BP 2.2 Casefinding – Medication that might be for HT but no HT Patients taking medication which might be for hypertension who don’t have an obvious indication for this.  
? Hypertension/BP 2.3 Casefinding – ABPM>=135/85 and not appropriately coded Patients with a home BP average reading >=135/85 (which defines hypertension) without a subsequent hypertension code.  
? Drug to Diagnosis 004 – Betablocker without obvious indication  Also likely to detect other diagnoses such as hypertension, heart failure, SVT, CHD 
? Drug to Diagnosis 005 – Calcium channel blocker without obvious indication  Also likely to detect other diagnoses such as hypertension, Raynauds, SVT, CHD 
? Drug to Diagnosis 007 – RAS Drug without obvious indication  Also likely to detect other diagnoses such as CHD, diabetic kidney disease, heart failure, LVSD 
? Drug to Diagnosis 009 – Thiazides without obvious indication   

From the Hypertension template, previous blood pressure readings, QoF hypertension codes and non-QoF possible indicators of Hypertension can be seen. 

Hypertension 
Has non-QoF code for hypertension 
systolic BP 
i 23Aug2011 
27 Mar 2012 
18Apr2013 
25 Jun 2014 
07 Jul 2014 
05 May 2015 
22Aug2016 
2gMar2017 
19 Dec2017 
04 Jul 2018 
12 Dec2018 
01 May201g 
13Jan2020 
27 Jan 2020 
28 Jun 2021 
11 Aug2021 
11 Aug2021 
26 2022 
30 May 2022 
O/E- Systolic BP reading 
O/E- Systolic BP reading 
O/E- Systolic BP reading 
O/E- Systolic BP reading 
O/E- Systolic BP reading 
O/E- Systolic BP reading 
O/E- Systolic BP reading 
O/E- Systolic BP reading 
O/E- Systolic BP reading 
O/E- Systolic BP reading 
O/E- Systolic BP reading 
O/E- Systolic BP reading 
O/E- Systolic BP reading 
O/E- Systolic BP reading 
O/E- Systolic BP reading 
O/E- Systolic BP reading 
Average home systolic blood pressure 
O/E- Systolic BP reading 
O/E- Systolic BP reading 
O/E - Systolic BP reading 
120 mmHg 
110 mmHg 
140 mmHg 
160 mmHg 
140 mmHg 
140 mmHg 
138 mmHg 
124 mmHg 
134 mmHg 
130 mmHg 
126 mmHg 
130 mmHg 
110 mmHg 
116 mmHg 
112 mmHg 
146 mmHg 
113 mmHg 
113 mmHg 
128 mmHg 
110 mmHg 
Diastolic BP 
23Aug2011 
27 Mar 2012 
18Apr2013 
25 Jun 2014 
07 Jul 2014 
05May2015 
22Aug2016 
2gMar2017 
19 Dec2017 
04 Jul 2018 
12 Dec2018 
01 May201g 
13Jan2020 
27 Jan 2020 
28 Jun 2021 
11 Aug2021 
11 Aug2021 
26 2022 
30 May 2022 
O/E- Diastolic BP reading 
O/E- Diastolic BP reading 
O/E- Diastolic BP reading 
O'E- Diastolic BP reading 
O/E- Diastolic BP reading 
O/E- Diastolic BP reading 
O/E- Diastolic BP reading 
O'E- Diastolic BP reading 
O/E- Diastolic BP reading 
O/E- Diastolic BP reading 
O/E- Diastolic BP reading 
O'E- Diastolic BP reading 
O/E- Diastolic BP reading 
O/E- Diastolic BP reading 
O/E- Diastolic BP reading 
O'E- Diastolic BP reading 
Average home diastolic blood pressure 
O'E- Diastolic BP reading 
O/E- Diastolic BP reading 
O/E - Diastolic BP reading 
78 mmHg 
70 mmHg 
go mmHg 
100 mmHg 
80 mmHg 
100 mmHg 
86 mmH 
74 mm 
80 mmH 
86 mm 
80 mmH 
80 mm 
70 mmH 
84 mm 
60 mmH 
84 mm 
82 mmH 
82 mm 
80 mmH 
74 mmHg 
Hypertension QoF Codes 
Hypertension Codes (non OOF) 
18 Jun 2022 8/0: hypertension
Patients to Target

The following reports will help target patients for intervention. They have been arranged in such a way to facilitate prioritisation.

These reports are in the folder CDRC Quality > Cardiovascular:

Report NameReturnsIntervention Notes 
? Hypertension/BP 3.1 Management Priority 1 – Highest potential for interventionPriority 1 patients.
Has all three of:
– 3 months overdue BP check.
– Suspected poor concordance.
– BP is >20/10 over NICE or personal target.
Review patient  
? Hypertension/BP 3.2 Management Priority 2 – High potential for interventionPriority 2 patients.
Has two out of three of:
– 3 months overdue BP check.
– Suspected poor concordance.
– BP is >20/10 over NICE or personal target.
Review patient Patients with stage 1 hypertension without end organ damage who are off treatment are not included. 
Patients are not included if the last blood pressure was recorded in the last 6w allowing time for recent intervention to have an effect 
? Hypertension/BP 3.31 Management Priority 3a – Consider treatment intensificationPriority 3a
Last BP is >30/15 above NICE or personal target.
Review patient and consider treatment intensificationPatients in priority 1 and 2 are excluded.
? Hypertension/BP 3.32 Management Priority 3b – Consider Poor ConcordancePriority 3b
Patients who need BP control who do not appear to be collecting antihypertensives
Consider review of concordance Patients in priority 1 and 2 are excluded.
? Hypertension/BP 3.33 Management Priority 3c – No BP check for 18mPriority 3c
Patients who need a BP check who are at least 6 months overdue
Consider inviting for review or requesting home BPPatients in priority 1 and 2 are excluded. This includes patients with AAA, CHD, CKD, diabetes, hypertension, heart failure, PAD, stroke/TIA.
? Hypertension/BP 3.41 Management Priority 4a – Consider treatment intensificationPriority 4a
Last BP is >20/10 above NICE or personal target
Review patient and consider treatment intensificationPatients in priority 1 and 2 are excluded.
? Hypertension/BP 3.43 Management Priority 4c – No BP check for 15mPriority 4c
Patients who need a BP check who are at least 3 months overdue a check
Consider inviting for review or requesting home BPPatients in priority 1 and 2 are excluded. This includes patients with AAA, CHD, CKD, diabetes, hypertension, heart failure, PAD, stroke/TIA.
? Hypertension/BP 3.5 Management Priority 5 – Consider treatment intensificationPriority 5
Last BP is above NICE or personal target
Review patient and consider treatment intensificationPatients in priority 1 and 2 are excluded.
? Hypertension/BP 3.6 Management Priority 6 – Consider setting personal targetPriority 6
Patients who need BP control who don’t have a personal target
Consider setting a BP targetIncludes:
– Hypertension (unless stage 1 without end organ damage
– Type 1 diabetes
– Diabetes with micro/albuminuria
– CKD
Performance Reports

The following reports allow units to assess their performance with respect to blood pressure management.  These searches cover people with any condition for which BP control is recommended – CKD, Diabetes, Hypertension and Stroke/TIA 

Templates

Hypertension CDRC Template

How to Access

In the lower left hand corner use the search bar, type in ‘Hypertension CDRC’ and select the following template:

Alternatively, press F12 and search for ‘Hypertension CDRC’, this will return the aforementioned template.

The Hypertension CDRC template facilitates the review of patients with hypertension. 

Hypertension InvestigationjReferral aoF Ruleset Exceptions Resources 
Hypertension 
BP Targets 
BP Graph 
BP Hypertension Register 
End Organ Damage 
Core Data 
Patient Resources 
BP Treatment 
BP Exceptions 
On max tol Rx 
011 Lipids 
Hypertension Review 
NICE Hypertension Summarv NICE Hypertension Guidance 
Estimated NICE Target <140 
OOF Target 
Target systolic bl < 140 17 Jan 2022 
Estimated NICE Target 
OOF Target 
Target diastolicb 17 Jan 2022 
14 Dec2021 0/E-SystoIi= 
12 Jan 2022 Average home 
31 Jan 2022 0/E 
18 Feb2022 0'E- 
Systolic 
15 Mar 2022 0/E 
- Systolic 
23 May 2022 0/E 
Has HYPERTENSION 
165m 
160 
120m 
146 
158m 
102m 
14 Dec 2021 
12 Jan 2022 
31 Jan2022 
18 Fe02022 
15Mar2022 
23 May 2022 
O'E- Diastolic 
Average home 
O'E- Diastolic 
O'E- Diastolic 
O'E- Diastolic 
O'E- Diastolic 
3737 KgJm• 
87 
12 May 2022 Body mass index - observation 
1 1 Nov 2020 Enjoys light exercise 
Current smoker 
Alcohol intake 
Indapamide 25mg tablets 
Losanan 100mg tablets 
10 Unitsmeek 
11 Nov2020 
27 Jun 2022 take on 
27 Jun 2022 take 
28 tablet 
28 tablet 
1226% 
28 tablet 
A QoF Achieved 
12 Mar 2022 
QRlSK2 cardiovascular disease 10 year risk score 
Atorwastatin 20mg tablets 
02 Jun 2022 take 
LIPID TARGET NOT ACHIEVED 
31 Jan 2022 Hypertension annual review 
Scripts aps 
Medication Timeline 
<Previous

The Hypertension CDRC template features: 

  • Information about estimated and actual BP targets with a link to the BP Target Setting template to record/update BP targets. QoF achievement is shown (this covers achievement for all BP related QoF indicators not just the hypertension domain). 
  • Recent blood pressure readings (of any type) and a link to the BP graph function. 
  • A panel which shows if the patient is on the hypertension register and specifically shows if the patient has stage 1 hypertension without end organ damage.  Information about end organ damage is shown here.  There are links to templates to add/remove patients from the hypertension register and to view and record information about End Organ Damage.   
  • A panel showing key lifestyle factors which contribute to hypertension.  There is a link to the Core Data template to record lifestyle factors and deliver interventions / referrals. There is a link to patient information to manage blood pressure 

The BP treatment panel shows current antihypertensive medication and will show prompts when applicable such as: 

  • Consider setting BP target 
  • Consider intensification of treatment 
  • Consider ACEi/A2RB when this is specifically indicated e.g. diabetic kidney disease 
  • Consider drug concordance when patients are not collecting antihypertensives. 

There is a link to the BP Treatment template which shows the NICE pathway for treating raised blood pressure.  There is also a link to record hypertension exception codes.  The Scripts and BPs button will show previous antihypertensives along with BP readings making it easier to review progress with current and previous treatment. 

CORC Treatment with 
All Previous Antihypertensive Medication 
Indapamide 25mg tablets 
Propranolol 10mg tablets 
Bisoprolol 25mg tablets 
Lisinopril 10mg tablets 
Lisinopril 25mg tablets 
Losanan 100mg tablets 
take one 3 times/day 
3 issues 
4 issues 
8 issues 
7 issues 
2 issues 
3 issues 
60 mmHg 
110 mmHg 
120 mmHg 
80 mmHg 
120 mmHg 
80 mmHg 
120 mmHg 
80 mmHg 
110 mmHg 
60 mmHg 
78 mmHg 
120 mmHg 
og sep 2013 
27 Jun 2022 
30 Apr 2020 
08 Apr 2022 
07 Apr 2022 
14 Jul 2021 
27 Jun 2022 
27 Mar 2006 
27 Mar 2006 
29 Aug 2006 
2g Aug 2006 
1 a oct 2006 
16 oct 2006 
27 Mar 2007 
27 Mar 2007 
15 Jul 2008 
15 Ju12008 
a Feb 2010 
6 Feb 2010 
O/E- Diastolic BP reading 
O/E- Systolic BP reading 
O/E- Systolic BP reading 
ONE- Diastolic BP reading 
O/E- Systolic BP reading 
O/E- Diastolic BP reading 
O/E- Systolic BP reading 
ONE- Diastolic BP reading 
O/E- Systolic BP reading 
O/E- Diastolic BP reading 
O/E- Diastolic BP reading 
ONE - Systolic BP reading 
Propranolol 10mg tablets
15 Mar2022 ONE - Diastolic reading 
15 Mar2022 ONE-Systolic reading 
Bisoprolol 25mg tablets 
Lisinopril 10mg tablets 
Lisinopril 10mg tablets 
Lisinopril 10mg tablets 
Lisinopril 10mg tablets 
Bisoprolol 25mg tablets 
Bisoprolol 25mg tablets 
Bisoprolol 25mg tablets 
Bisoprolol 25mg tablets 
Bisoprolol 25mg tablets 
Bisoprolol 25mg tablets 
Indapamide 25mg tablets 
Losartan 100mg tablets 
23 May2022 ONE- Diastolic reading 
23 May2022 0/E-systoIic8P reading 
Indapamide 25mg tablets 
Losartan 100mg tablets 
Losanan 100mg tablets 
Indapamide 25mg tablets 
take one daily 
take one daily 
take one daily 
take one daily 
take one daily 
take one daily 
take one daily 
take one daily 
take one daily 
take one daily 
take one daily 
take one each morning 
take one daily 
take one each morning 
take one daily 
take one daily 
take one each morning 
84 mmHg 
158 mmHg 
04 Apr 2022 
07 Apr 2022 Q 
02 Jun 2022 
05 May 2022 
07 Apr 2022 
26 Aug 2022 
2g Jul 2022 
01 Jul 2022 
03 Jun 2022 
06 May 2022 
08 Apr 2022 
06 May 2022 
06 May 2022 
64 mmHg 
102 mmHg 
06 Jun 2022 Q 
06 Jun 2022 Q 
27 Jun 2022 
27 Jun 2022

There is a panel showing information and CVD risk and lipid lowering therapy with a link to the lipid template 

There is space to record that the review has been completed along with any relevant comments.  The most recent review (and any comments) are shown in the panel alongside. 

Blood Pressure Target Setting

How to Access

In the lower left hand corner use the search bar, type in ‘BP Targets’ and select the following template:

Alternatively, press F12 and search for ‘BP Targets’, this will return the aforementioned template.

The BP Target template shows estimated targets (NICE and QoF as these are not always aligned) and allows recording of patient specific targets.  If a target is set which is not the default, it is helpful to record this as free text with the target – this free text will be displayed in the panel on the right. 

NICE Targets Targets Resources 
BP Targets (NICE) 
Estimated NICE Target <140 
QoF Target 
Target systolic ap 
Target diastolic ap 
Clinic BP 
Estimated NICE Target 
QoF Target 
17 Jan 2022 
17 Jan 2022 
CKD and ACR 
OR 
TIDM AND 2 features ot 
metabolic syndrome 
OR 
TIDM AND albuminuria 
Type 1 diabetes 
CKD 
OR 
Hypertension under 80y 
Hypertension 80y + 
< 130/80 
< 135/85 
< 140/90 
< 150/90 
ABPM or 
HBPM 
< 135/85 
< 145/85 
Target 
Systolic 
120-129 in 
CKD 
120-139 in 
CKD 
A QoF Achieved 
Target systolic blood pressure 
Target diastolic blood pressure 
NO clear record of code for CKD 
No record of diabetes 
Show Renal Va Iues 
NICE Hypertension 
< 140 mm Hg 
< go mm Hg 
RCP stroke
Blood Pressure Treatment

How to Access

In the lower left hand corner use the search bar, type in ‘BP Treatment CDRC’ and select the following template:

Alternatively, press F12 and search for ‘BP Treatment’, this will return the aforementioned template.

The BP Treatment template provides guidance about how to treat blood pressure. The home page sets out BP targets, current treatment and the NICE pathway. 

BP When to Treat AF 
BP Treatment 
Targets 
CHO 
CKD Diabetes Gout Heart Failure 
Estimated NICE Target <140 
OOF Target 
Target systolic bloom < 140 
Indapamide 25mg tablets 
Losanan 100mg tablets 
=55y (not diabetic) 
17Jan2022 
Estimated NICE Target 
OOF Target 
Target diastolic bloomsgo 17 Jan 2022 
NICE Hypertension Pathway 
Diabetes OR 
<55y not African/Caribbean 
step 1 ACEI/A2R8 
step2 AC 
I/A2R8 + cca or TLD 
step 3 
African/Caribbean (not diabetic) 
cca if ccanot tolerated) 
cca + ACEi/A2R8* or TLD 
27 Jun 2022take 28 tabl... 
Antihypertensive Scripts * aps 
27 Jun 2022take 28 
Medication Timeline 
Relevant Conditions 
hite British - ethnic category 2001 censusß 
21 Nov2017 W 
No record of AF 
NO clear record of CHO 
NO clear record of code for CKD 
No record of diabetes 
ACEi/A2R8 + cca + thiazjde-like diuretic 
Step 4 Consider low dose spironolactone (25mg) if K«4S 
If spironolactone not tolerated, ineffective or 
contraindicated, consider alpha or beta blocker 
Thiazide-like diureticslndapamide - 2Smg (or 1 snig MR) cd - DO NOT INCREASE DOSE 
Chlortalidone - intialty 12Smg-2Smg od- can be increased to SOmg 
NS a dose of 12Smg chlortalidone requires quartering of a tablet 
•ACEA2RBs 
Consider A2RB instead of ACEi n Africans/Cariböeans 
Different pathways may be recommended in the conditions below. 
Diabetes 
CHO 
Gout 
CKD 
Heal Failure

The When to Treat Page, provides guidance on when to start treatment.

ap When to Treat AF CHO CKD Diabetes Gout Heart Failure 
When to Start Treatment for Hypertension 
NICE 
stage 1 Hypertension (El 40/90 or ABPM/HBPM 35/85) 
Start treatment if: 
Under 80 AND at least one of 
• Target organ damage 
• Established cardiovascular disease 
• Diabetes 
• Renal disease 
• loy CVD risk 
• If under 60, consider Rx if 
(QRISK underestimates lifetime risk in ßunger people) 
stage 2 Hypertension (El 60/100 ABPWHBPM El 50/95) 
Offer treatment to all 
18 Feb2022 
18 Fe02022 
15Mar2022 
15Mar2022 
23 May 2022 
23 May 2022 
O/E - Diastolic BP reading 
ONE - Systolic BP reading 
O/E- Diastolic BP reading 
O/E- Systolic BP reading 
O/E- Diastolic BP reading 
O/E- Systolic BP reading 
NO clear record of CHO 
NO clear record of code for CKD 
No record of diabetes 
No record of peripheral arterial disease 
No record of stroke'TlA 
Target Organ Damage 
unne albumin/creatinine ratio 
Urinary Blood 
05 Nov 2008 Unne blood test = negative 
02 Apr 2014 Urine blood test = negative 
05 Feb 2017 unne blood test 
Cardiovascular Risk 
QRlSK2 cardiovascular disease 10 year 
06 mg/mmol 
12.26% 
87 mmHg 
146 mmHg 
84 mmHg 
158 mmHg 
64 mmHg 
102 mmHg 
07 Jul 2021 
12 Mar 2022

There is also Disease specific pages which hosts guidance.

BP When to Treat AF CHO CKD Diabetes 
Heart Failure and Hypertension 
NICE 
Gout 
Heart Failure 
For all patients with heart failure avoid verapamil, diltiazem and short acting CCBs 
Patients with left ventricular systolic dysfunction should usually be offered a: 
ACEi ( or A2RB if ACEi not tolerated ) 
AND 
Beta - blocker licensed for heart failure 
For patients with heart failure and preserved LV function no specific treatment is 
Hypertension with CKD Information 
GFR calculated abbreviated > go ml_.L 
GFR calculated abbreviated„75 
GFR calculated abbreviated > go mu 
06 Jul 2021 
31 Jan 2022 
23 May 2022 
23 May 2022 
Serum creatinine level 
Serum potassium level 
66 umol/L 
4 6 mmoI/L23 May 2022 
unne protein/creatinine ratio No numer„ 
Urine albumin/creatinine ran 06 mgJnm„ 07 Jul 2021 
ACEi/A2R8 Exceptions 
recommended. 
Target Doses 
Drug 
Enalapril 
Lisinopril 
Perindopril 
Ramipril 
Candesanan 
Losanan 
Valsanan 
Bisoprolol 
Carvedllol 
Nebl%.olol 
Starting Dose 
25mg 
25mg 
2mg 
125mg 
4 mg 
12 5mg 
40mg Od 
1 25mg od 
3 125mg bd 
125mg od 
Target Dose 
10-20mg bd 
20-35mg od 
4mg od 
5mg bd or 10mg od 
32mg od 
150mg od 
160mg Od 
10mg od 
25-50mg bd 
10mg od 
Notes 
mg if symptomatic with 
10mg 
30-35mg if symptomatic 
with 20mg 
Divided doses 
recommended 
25 mg target if <85kg or 
Severe H F 
Licensed for over 70s
Hypertension End Organ Damage

How to Access

In the lower left hand corner use the search bar, type in ‘Hypertension End Organ Damage’ and select the following template:

Alternatively, press F12 and search for ‘Hypertension End Organ Damage’, this will return the aforementioned template.

The Hypertension End Organ Damage template shows relevant information. 

Previous information about renal function/proteinuria/haematuria can be displayed by clicking the <Expand button 

The last ECG can be viewed by right clicking on it and choosing View content. 

Hypertension End Organ Damage 
Conditions suggesting end organ damage include: 
CHO 
Heal failure 
Left ventricular hypertrophy 
Stroke 
Kidney Damage 
Assess renal function 
Assess renal protein loss 
Urine blood 
Eye Damage 
Fundoscopy 
ECG Changes 
12 lead ECG 
No record of AF 
NO clear record of CHO 
NO clear record of code for CKD 
No record of heart failure 
No record of peripheral arterial disease 
No record of strokefflA 
23 May 2022 
23 May 2022 
07 Jul 2021 
07 Jul 2021 
02 Apr 2014 
5 Feb 2017 
Serum creatinine level 
GFR calculated abbreviated MDRD 
Urine albumin/creatinine ratio 
Urine albumin/creatinine ratio 
Urine blood test = negative 
Urine blood test 
66 umol/L 
> go mUminm 
0.6 mgJmmol 
<Expand 
CDRC Fundoscopy (last) view has no data for patient 
C] 
16 Nov 2007 
06 Jul 2021 
06 Jul 2021 
ECG normal 
ECG to Leadgate Surgery 
121eadECG
16Nov2007 
16Nov2007 
05 Nov2008 
28 Mar 2011 
28 Mar 2011 
31 Jul 2012 
31 Jul 2012 
02 Apr 2014 
17 Apr2014 
17 Apr2014 
17 Apr2014 
05Fe02017 
21 Nov2017 
21 Nov2017 
08 Apr 2020 
08 Apr 2020 
11 Nov2020 
11 Nov2020 
07 Jul 2021 
07 Jul 2021 
31 Jan2022 
31 Jan2022 
23 May 2022 
23May2022 
GFR calculated abbreviated MDRD 
Serum creatinine level 
GFR calculated abbreviated MDRD 
Serum creatinine level 
Urine blood test = negative 
GFR calculated abbreviated MORO 
Serum creatinine level 
GFR calculated abbreviated MORO 
Serum creatinine level 
Urine blood test = negative 
GFR calculated abbreviated MDRD 
GFR calculated abbreviated MORO 
Serum creatinine level 
Urine blood 
GFR calculated abbreviated MDRD 
Serum creatinine level 
GFR calculated abbreviated MDRD 
Serum creatinine level 
GFR calculated abbreviated MDRD 
Serum creatinine level 
GFR calculated abbreviated MDRD 
Serum creatinine level 
Urine albumin/creatinine ratio 
Urine albumin/creatinine ratio 
Serum creatinine level 
GFR calculated abbreviated MORO 
Serum creatinine level 
GFR calculated abbreviated MORO 
70 umol/L 
70 umol/L 
76 mumin/1 73m*2 
74 umol/L 
63 u mol/L 
> go mumin/1.73m*2 
61 umol/L 
> go mumin/1.73m*2 
65 umol/L 
> go munmn/1.73m*2 
64 umol/L 
> go munmn/1.73m*2 
62 umol/L 
> go munmn/1.73m*2 
61 umol/L 
116 mg/mmol 
79 umoI/L 
75 mumin/1 73m*2 
66 umol/L 
> go mumin/1 73m*2
Recording Blood Pressure

How to Access

In the lower left hand corner use the search bar, type in ‘BP Detailed Blood Pressure’ and select the following template:

Alternatively, press F12 and search for ‘BP Detailed Blood Pressure’, this will return the aforementioned template.

Blood pressure can be recorded on the Core Data Entry template or more detailed blood pressure information can be seen/recorded on the BP Detailed Blood Pressure template which be reached from the Core Data Entry template or added to existing toolbars or templates. 

The BP Detailed Blood Pressure template has the following features 

Column 1 Column 2 Column 3 
Space to record specific requirements for BP recording e.g. cuff size, which are to use/avoid Most recent blood pressure monitoring comments  
Link to BP Targets setting template Current estimated NICE BP target Current QoF target Current patient specific target (if this has been set) Indicator to describe current QoF performance regarding blood pressure (all QoF domains) 
Link to BP Exceptions template   
Space to record various clinic BPs Most recent BP readings (all types) Link to BP Graph which shows more detailed information about previous BP reading in data or graphical form 
Relevant home blood pressure codes Link to a printable home BP record sheet Link to the Communication Annexe to send SMS or email links for a BP recording sheet. Link to an average calculator Space to record home or ambulatory BP Relevant information about previous home and ambulatory BP readings and codes  

The Guidance page has information about recording blood pressure and diagnosing hypertension 

The Resources page has links to professional resources and a button to link to patient resources 

Blood Pressure at Home

Supporting Blood Pressure at Home

The following resources are available to support Blood Pressure at home. 

Reports

The following searches will help identify patients who might benefit from blood pressure measurements at home. 

These reports are found in the folder CDRC Quality > Cardiovascular 

Report 1.10 identifies patients who need BP management (hypertension, diabetes, CKD) who have not achieved the NICE target for their combination of risk factors, unless they have a target BP recorded that has been achieved.   People with moderate or severe frailty, care home residents and palliative care stages B/C/D are excluded. 

Report 1.11 identifies patients in 1.10 who have had a record (in the past 12 months) of home BP measurement, referral for home BP, home BP not indicated, home BP declined. 

The other searches use the same criteria but identify patients at increasing levels of risk, based on factors such as last BP level, comorbidities, history of engagement, concordance. 

Template 

Use the BP Detailed Blood Pressure template, highlighted above, to record relevant information and values 

Use the PIL Hypertension and Blood Pressure template below for providing patient information. 

Additional Resources

Hypertension and Blood Pressure Patient Information Leaflet

This Patient Information template has links to useful patient resources – both weblinks and some printable resources for use from face to face consultations. 

There is a link to the Communication Annexe which makes it easy to send information electronically to patients. This also allows the patient to send completed BP sheets back to the practice. 

Hypertension Opt-in Resources

For practices who have recently joined the DCS group on SystmOne, PSAs and Protocols will not be automatically active. You can choose the level of activation you would like; opt-in to all or resource specific CDRC resource PSAs and Protocols. Alternatively you can choose not to opt-in and only use the Reports and Templates.

If you would like to activate that following, or all, CDRC PSAs and Protocols, please email contact-cdrc@ahsn-nenc.org.uk

The following resources are available to support Hypertension, Blood Pressure management and QoF Performance:

Resource Trigger Action 
Raised BP PSA (icon) Displays for patients not on the hypertension register with raised BP Consider repeat BP or home BP 
BP Target Protocol Will trigger if the patient’s estimated BP target changes e.g. at new hypertension diagnosis Consider adding a BP target 

Footer

Follow us on social media

  • Facebook
  • LinkedIn
  • Twitter
  • Terms of Reference
  • Ethics & Governance
  • Privacy policy
  • Terms of use
  • Join CDRC Precision

Copyright © 2023 Clinical Digital Resource Collaborative